Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Fibronectin gene polymorphism in patients with lung cancer
Autore:
Siemianowicz, K; Gminski, J; Francuz, T; Syzdol, M; Polanska, D; Machalski, M; Brulinski, K; Magiera-Molendowska, H;
Indirizzi:
L Warynski Silesian Med Acad, Dept Expt & Clin Biochem, PL-40752 Katowice,Poland L Warynski Silesian Med Acad Katowice Poland PL-40752 52 Katowice,Poland L Warynski Silesian Med Acad, Dept Internal Dis 1, PL-40029 Katowice, Poland L Warynski Silesian Med Acad Katowice Poland PL-40029 9 Katowice, Poland Silesian Hosp TB & Lung Dis, PL-43360 Bystra Slaska, Poland Silesian Hosp TB & Lung Dis Bystra Slaska Poland PL-43360 Slaska, Poland Municipal Hosp 6, PL-40074 Katowice, Poland Municipal Hosp 6 Katowice Poland PL-40074 p 6, PL-40074 Katowice, Poland
Titolo Testata:
ONCOLOGY REPORTS
fascicolo: 6, volume: 8, anno: 2001,
pagine: 1289 - 1292
SICI:
1021-335X(200111/12)8:6<1289:FGPIPW>2.0.ZU;2-L
Fonte:
ISI
Lingua:
ENG
Soggetto:
CELL-LINES; INSITU HYBRIDIZATION; TAQI RFLP; FN1 GENE; CARCINOMA; MIGRATION; INVASION; FIBROBLASTS; PROTEIN; TISSUES;
Keywords:
lung cancer; fibronectin; restriction fragment length polymorphisms;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
36
Recensione:
Indirizzi per estratti:
Indirizzo: Siemianowicz, K L Warynski Silesian Med Acad, Dept Expt & Clin Biochem, UlMedykow 18, PL-40752 Katowice, Poland L Warynski Silesian Med Acad Ul Medykow 18 Katowice Poland PL-40752
Citazione:
K. Siemianowicz et al., "Fibronectin gene polymorphism in patients with lung cancer", ONCOL REP, 8(6), 2001, pp. 1289-1292

Abstract

Fibronectin (FN) is a glycoprotein component of connenctive tissue. It is involved in cancer progression. FN plays a role in non-neoplasmatic lung pathology in which fibronectin gene polymorphisms (RFLPs) have been studied. The aim of our work was to evaluate the frequency of two of fibronectin RFI-Ps: genotypes AB, AA, BB (HaeIII) and CD, CC, DD (MspI) in patients with lung cancer. The studied group consisted of 63 patients with squamous cell lung cancer and 53 controls without any malignant or proliferative disease. There were no statistically significant differences in the distribution of studied genotypes between lung cancer patients and controls.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 23:05:46